|
Reason for the notification
|
|
|
Initial notification / Amendment
|
Initial notification
|
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
|
Name
|
Smith & Nephew plc
|
|
LEI
|
213800ZTMDN8S67S1H61
|
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
|
|
Description
of the financial instrument, type of instrument
|
Smith
& Nephew plc ordinary shares of USD 0.20 each
|
|
Identification code
|
ISIN: GB0009223206
|
|
Nature of the transaction
|
Vesting of Conditional Share awards granted under the Smith &
Nephew Global Share Plan 2020, and subsequent sale of shares to
cover tax liability
|
|
Date of Transaction
|
2026 - 05 – 19
|
|
Place of Transaction
|
London Stock Exchange (XLON)
|
|
Name (Position)
|
Status
|
Price (£)
|
Volume
|
Aggregated information
|
|
Rohit Kashyap
(President, Advanced Wound Management and Global Commercial
Operations)
|
PDMR
|
11.426512
|
11,949 (of which 4,719 were sold and 7,230 were
retained)
|
N/A Single Transaction
|
|
|
|
|
|
|
|
Smith & Nephew plc
|
|
|
|
(Registrant)
|
|
|
|
|
|
|
|
|
|
Date:
May 20, 2026
|
By:
|
/s/
Helen Barraclough
|
|
|
|
Helen
Barraclough
|
|
|
|
Company
Secretary
|